Percheron Therapeutics LimitedASX: PER

ANP Submits US Orphan Drug application for ATL1102 in DMD

Aug 3, 2020 at 3:56 AM UTC · Issued by Percheron Therapeutics Limited

Percheron Therapeutics Limited has released a press release.

View Attachment